Last updated on February 2018

Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Community Acquired Pneumonia
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients 18 years of age or older admitted to hospital with community acquired pneumonia defined as a new infiltrate on x-ray and at least one of the following; cough, expectoration, dyspnea, fever and pathological lung-auscultation.
  • Not admitted to hospital within the last 14 days
  • The patients has been prescribed antibiotic treatment for pneumonia
  • The patient can comprehend the written and verbal information and has provided written consent.

Exclusion Criteria:

  • Patient are unable to give written consent or patient does not understand the Danish language.
  • Active pulmonary tuberculosis
  • Severe immunosuppression determined by the treating physician (i.e. treatment with highdose corticosteroid for more than 2 weeks, chemotherapy and neutropenia with neutrophils < 0.5x109/l, ongoing treatment with biological drugs, chronic HIV-infection with CD4 cell count < 350 mio./l, immunosuppression after organ transplantation).
  • Pregnancy and breastfeeding
  • Patients admitted to hospital and treated against their will.
  • Terminal ill patients where active treatment is stopped within the first 48 hours of admission.
  • Patients who are, from the date of inclusion, prescribed antibiotic treatment for more than 3 days on a different indication than pneumonia.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.